We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+11.44%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.81B
AUM Growth
+$194M
Cap. Flow
+$40.5M
Cap. Flow %
2.24%
Top 10 Hldgs %
63.7%
Holding
392
New
24
Increased
176
Reduced
102
Closed
74

Top Buys

Rank Stock Value
1
FUTU icon
Futu Holdings
FUTU
+$32.5M
2
AMAT icon
Applied Materials
AMAT
+$26.5M
3
AAPL icon
Apple
AAPL
+$13.7M
4
MSFT icon
Microsoft
MSFT
+$11.9M
5
NVDA icon
NVIDIA
NVDA
+$9.49M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$28.3M
2
BEKE icon
KE Holdings
BEKE
+$13.2M
3
TSM icon
TSMC
TSM
+$13.2M
4
ASX icon
ASE Group
ASX
+$7.59M
5
IQ icon
iQIYI
IQ
+$6.13M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 39.73%
2 Technology 31.74%
3 Communication Services 9.52%
4 Healthcare 5.08%
5 Financials 4.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLDR icon
326
Builders FirstSource
BLDR
$7.29B
-3,981
Closed -$830K
BMEA icon
327
Biomea Fusion
BMEA
$125M
-22,605
Closed -$338K
BRBR icon
328
BellRing Brands
BRBR
$1.24B
-3,995
Closed -$236K
CDNA icon
329
CareDx
CDNA
$2.58B
-17,239
Closed -$183K
CELH icon
330
Celsius Holdings
CELH
$8.35B
-7,742
Closed -$642K
COIN icon
331
Coinbase
COIN
$47.1B
-2,567
Closed -$681K
COO icon
332
Cooper Companies
COO
$13.9B
-2,038
Closed -$207K
CP icon
333
Canadian Pacific Kansas City
CP
$82.7B
-5,099
Closed -$450K
CRBU icon
334
Caribou Biosciences
CRBU
$174M
-25,586
Closed -$132K
CRL icon
335
Charles River Laboratories
CRL
$13.9B
-739
Closed -$200K
DGX icon
336
Quest Diagnostics
DGX
$26.8B
-1,593
Closed -$212K
EDU icon
337
New Oriental
EDU
$9.36B
-15,528
Closed -$1.35M
ETNB
338
DELISTED
89bio
ETNB
-21,830
Closed -$254K
FDMT icon
339
4D Molecular Therapeutics
FDMT
$810M
-7,351
Closed -$234K
HUBB icon
340
Hubbell
HUBB
$24.3B
-1,869
Closed -$776K
ILMN icon
341
Illumina
ILMN
$32.6B
-2,956
Closed -$395K
IRON icon
342
Disc Medicine
IRON
$3.07B
-4,861
Closed -$303K
KROS icon
343
Keros Therapeutics
KROS
$219M
-5,648
Closed -$374K
KURA icon
344
Kura Oncology
KURA
$1.13B
-14,710
Closed -$314K
LH icon
345
Labcorp
LH
$27.2B
-942
Closed -$206K
LOW icon
346
Lowe's Companies
LOW
$117B
-870
Closed -$222K
LQD icon
347
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
-7,900
Closed -$860K
MCO icon
348
Moody's
MCO
$89.2B
-1,425
Closed -$560K
MDB icon
349
MongoDB
MDB
$35.9B
-604
Closed -$217K
MDXG icon
350
MiMedx Group
MDXG
$656M
-13,622
Closed -$105K

Similar funds

E Fund Management's Q2 2024 Portfolio in Review

As of Q2 2024, E Fund Management held 392 positions worth $1.81B, up 12% from $1.61B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

E Fund Management's Q2 2024 filing shows 24 new, 176 increased, 102 reduced and 74 closed positions. Its largest new stake was Futu Holdings: 480,000 shares worth $31.5M. The largest sale was Advanced Micro Devices, an estimated $28.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.

  • E Fund Management's largest Q2 2024 buy was Futu Holdings: 480,000 shares worth $31.5M.
  • E Fund Management added most to Applied Materials in Q2 2024, an estimated $26.5M increase.
  • E Fund Management's biggest Q2 2024 reduction was Advanced Micro Devices, cutting an estimated $28.3M.
  • E Fund Management fully exited Yum China in Q2 2024, selling an estimated $5.17M.
  • E Fund Management's ten largest holdings make up 64% of its $1.81B portfolio in Q2 2024.
  • E Fund Management opened 24 new positions and closed 74 in Q2 2024.
  • E Fund Management's portfolio value rose 12% quarter-over-quarter to $1.81B.

Based on E Fund Management's 13F filing for Q2 2024, filed 12 Aug 2024.